(DAUG) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
DAUG: Options, ETF, Index, Stocks
The FT Cboe Vest U.S. Equity Deep Buffer ETF - August (BATS:DAUG) is designed to provide investors with exposure to the S&P 500 while incorporating a buffer against potential losses. Under normal market conditions, the fund allocates substantially all its assets to FLEX Options, which are exchange-traded, customizable option contracts. These options are tied to the performance of the SPDR® S&P 500® ETF Trust, allowing the fund to implement a structured outcome strategy. The use of FLEX Options enables the fund to customize key terms such as strike prices, expiration dates, and option styles, providing a tailored investment approach. The fund is non-diversified, meaning it can concentrate its investments in a limited number of securities, which may increase risk but also allows for targeted exposure to the underlying index.
As a defined outcome ETF, DAUG focuses on delivering specific risk-return profiles. Its strategy is designed to buffer against market downturns while participating in potential upside, within predetermined parameters. The funds structure is intended to appeal to investors seeking equity exposure with downside protection, particularly during periods of heightened volatility. The FLEX Options strategy allows the fund to lock in specific outcomes, such as limiting losses to a certain percentage over a defined period, while still offering upside potential. This makes it a tool for risk-managed equity allocation in investor portfolios.
Based on the provided
Over the next three months, DAUG is expected to trade within a narrow range, supported by its structured outcome strategy. The SMA 20 and SMA 50 are closely aligned at 40.35 and 40.12, respectively, indicating a stable trend. The SMA 200 at 38.95 suggests long-term support around the 39 level. The ATR of 0.20 points to limited volatility, with potential price fluctuations confined to a tight range. Given its current price of 40.11, DAUG is likely to oscillate between 39.90 and 40.40 in the short term, with minimal downside risk due to its buffer mechanism. The funds AUM of $316.60M USD reflects moderate investor interest, with average daily volume of 12,013 shares suggesting manageable liquidity.
Additional Sources for DAUG ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DAUG ETF Overview
Market Cap in USD | 310m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2019-11-06 |
DAUG ETF Ratings
Growth 5y | 63.0% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -3.35 |
Analysts | - |
Fair Price Momentum | 37.01 USD |
Fair Price DCF | - |
DAUG Dividends
No Dividends PaidDAUG Growth Ratios
Growth Correlation 3m | 4.9% |
Growth Correlation 12m | 95% |
Growth Correlation 5y | 64.9% |
CAGR 5y | 7.30% |
CAGR/Max DD 5y | 0.48 |
Sharpe Ratio 12m | 1.53 |
Alpha | -1.07 |
Beta | 0.37 |
Volatility | 14.34% |
Current Volume | 5.8k |
Average Volume 20d | 14.4k |
As of March 14, 2025, the stock is trading at USD 38.44 with a total of 5,800 shares traded.
Over the past week, the price has changed by -2.33%, over one month by -5.21%, over three months by -4.09% and over the past year by +4.61%.
Yes. Based on ValueRay Analyses, FT Cboe Vest U.S. Equity (BATS:DAUG) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.99 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DAUG as of March 2025 is 37.01. This means that DAUG is currently overvalued and has a potential downside of -3.72%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to ValueRays Forecast Model, DAUG FT Cboe Vest U.S. Equity will be worth about 40.3 in March 2026. The stock is currently trading at 38.44. This means that the stock has a potential upside of +4.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 40.3 | 4.8% |